Skip to Main Content

Paper Details

Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial.
Cancer Discov
77
2021
Author NameAffiliation
Suzanne CarreiraThe Institute of Cancer Research
Alec PaschalisThe Institute of Cancer Research
Alec PaschalisThe Royal Marsden NHS Foundation Trust
Susana MirandaThe Institute of Cancer Research
Wei YuanThe Institute of Cancer Research
Joaquin MateoThe Institute of Cancer Research
Joaquin MateoVall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital
Joaquin MateoThe Royal Marsden NHS Foundation Trust
Johann S de BonoThe Institute of Cancer Research
Johann S de BonoThe Royal Marsden NHS Foundation Trust
  • 1 - 10

Datasets

Release 1.2